58470 people have viewed this drug in the last 60 days
Updated 2025-10-03
| Last Update | 2022-08-31 |
| Register Year | 2017 |
| Product Type | Human |
| Drug Type | NCE |
| Scientific Name | NATALIZUMAB |
| Trade Name | TYSABRI 300 MG/15ML |
| Strength Unit | mg/ml |
| Pharmaceutical Form | Concentrate for solution for infusion |
| Administration Route | Intravenous use |
| Atc Code1 | |
| Atc Code2 | |
| Size | 15 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 1 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $5558.25 |
| Shelf Life | 48 Months |
| Marketing Company | Biogen Idec B.V-Natherland |
| Marketing Country | Netherlands |
| Manufacture Name | VETTER PHARMA-FERTIGUNG, GMBH & CO. KG |
| Manufacture Country | Germany |
| Secondry package manufacture | |
| Main Agent | Salehiya Trading Co. |
| Secosnd Agent | |
| Third Agent | |
| Visits | 58470 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| Tysabri | $5558.25 | 273369 visits | 2022-08-01 |
| TYSABRI 300 MG/15ML | $5558.25 | 58470 visits | 2022-08-31 |